Takeda Pharmaceutical Company Limited American Depositary Shares (each
TAK Real Time Price USDRecent trades of TAK by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TAK's directors and management
Government lobbying spending instances
-
$970,000 Oct 18, 2024 Issue: Budget/Appropriations Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$1,050,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$460,000 Apr 22, 2024 Issue: Defense Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$510,000 Jan 19, 2024 Issue: Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
-
$1,380,000 Oct 20, 2023 Issue: Budget/Appropriations Trade (domestic/foreign) Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TAK in WallStreetBets Daily Discussion
Recent insights relating to TAK
Recent picks made for TAK stock on CNBC
ETFs with the largest estimated holdings in TAK
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TAK Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.